Comment Re:Im not an immunologist... (Score 1) 73
Short answer: Yes, in theory.
Unproven therapies usually start out by treating patients with no other good options. Without good data, there is no reason to believe the new therapy is better than the standard of care - that's the whole point of late stage trials.
As doctors and the FDA and insurance companies and patients get more convinced that a therapy is useful, there will be a push to use it at an earlier line of therapy, and the company will run trials in earlier stage patients. Eventually, this could be used as a first line treatment if it proves better than the other options, but it's not statistically convincing yet, so it would be considered unethical to withhold the standard of care in favor of the vaccine.
Combinations of treatments (standard of care + vaccine vs. standard of care alone) are difficult because they are expensive (the vaccine manufacturer would have to pay for all drug for all enrolled patients) and the combination could potentially have increased toxicity.
Unproven therapies usually start out by treating patients with no other good options. Without good data, there is no reason to believe the new therapy is better than the standard of care - that's the whole point of late stage trials.
As doctors and the FDA and insurance companies and patients get more convinced that a therapy is useful, there will be a push to use it at an earlier line of therapy, and the company will run trials in earlier stage patients. Eventually, this could be used as a first line treatment if it proves better than the other options, but it's not statistically convincing yet, so it would be considered unethical to withhold the standard of care in favor of the vaccine.
Combinations of treatments (standard of care + vaccine vs. standard of care alone) are difficult because they are expensive (the vaccine manufacturer would have to pay for all drug for all enrolled patients) and the combination could potentially have increased toxicity.